| abstract |
Formula (I): (Wherein the variable groups are as described in the specification), and substituted cinnolin-4-ylamines are provided. Such compounds are ligands used to modulate specific receptor activity in vitro and in vivo and are particularly useful for the treatment of diseases associated with pathological receptor activity in humans, pets and livestock. It is. Also provided are pharmaceutical compositions using such compounds and methods for treating such diseases, as well as methods for using such ligands in receptor localization studies. |